Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma

Published:2016-07 Issue:1 Volume:377 Page:1-10
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lin Chengzhong,Lu Wei,Ren Zhenhu,Tang Yu,Zhang Chunye,Yang Rong,Chen Yiming,Cao Wei,Wang Lizhen,Wang Xu,Ji Tong

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai Municipality

Science and Technology Commission of Shanghai Municipality

Cross Research Foundation of Medicine and Science of Shanghai Jiao Tong University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. RET tyrosine kinase signaling in development and cancer;Arighi;Cytokine Growth Factor Rev,2005

2. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains;Takahashi;Oncogene,1988

3. Direct interactions among Ret, GDNF and GFRalpha1 molecules reveal new insights into the assembly of a functional three-protein complex;Amoresano;Cell. Signal,2005

4. A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation;Esposito;PLoS ONE,2008

5. Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification;Tanizaki;Br. J. Cancer,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation;Cancer Letters;2024-05

2. New insights into RAS in head and neck cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

3. EGFR Inhibitor CL-387785 Suppresses the Progression of Lung Adenocarcinoma;Current Molecular Pharmacology;2023-04

4. Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry;Clinical Cancer Research;2022-12-12

5. An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016–present);Expert Opinion on Therapeutic Patents;2022-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3